Product: Drugs Recipient: Recipient Name Mr. Denis Martin Recipient Title Operations Director Laboratoires Clarins 5 rue Ampére95300 PontoiseFrance Issuing Office: Center for Drug Evaluation and Research […]

On January 26, 2023, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) for adjuvant treatment following resection and platinum-based chemotherapy for stage IB (T2a […]

Recognized Interpretive Criteria Minimum InhibitoryConcentrations(mcg/mL) Disk Diffusion(zone diameter in mm) Pathogen S I R S I R Enterobacterales M100 standard is recognized Haemophilus influenzae and parainfluenzae […]

Recognized Interpretive Criteria Minimum InhibitoryConcentrations(mcg/mL) Disk Diffusion(zone diameter in mm) Pathogen S I R S I R Enterobacterales M100 standard is recognized Staphylococcus spp. M100 standard […]

Recognized Interpretive Criteria Additional FDA-identified interpretive criteria Minimum InhibitoryConcentrations(mcg/mL) Disk Diffusion(zone diameter in mm) Pathogen S I R S I R Enterobacterales M100 standard is recognized […]

FDA-Identified Interpretive Criteria   Minimum InhibitoryConcentrations(mcg/mL) Disk Diffusion(zone diameter in mm) Pathogen S I R S I R Staphylococcus aureus(including methicillin-resistantisolates) ≤0.5a – – ≥19 – […]

Recognized Interpretive Criteria   Minimum InhibitoryConcentrations(mcg/mL) Disk Diffusion(zone diameter in mm) Pathogen S I R S I R Enterobacterales M100 standard is recognized Pseudomonas aeruginosa M100 […]

Recognized Interpretive Criteria Minimum InhibitoryConcentrations(mcg/mL) Disk Diffusion(zone diameter in mm) Pathogen S I R S I R Enterobacterales M100 standard is recognized Acinetobacter spp. M100 standard […]

Recognized Interpretive Criteria Minimum Inhibitory Concentrations(mcg/mL) Disk Diffusion(zone diameter in mm) Pathogen S I R S I R Enterobacterales – – – M100 standard is recognized […]